Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Marlene Smurzynski"'
Autor:
Yan Wang, Andrew Rava, Marlene Smurzynski, Bonny Shah, Anusorn Thanataveerat, Imad Al-Dakkak, Moh-Lim Ong, Christopher C. Dvorak, Vincent T. Ho
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
BackgroundThrombotic microangiopathy (TMA) associated with hematopoietic stem cell transplantation (HSCT-TMA) is a serious post-transplant complication. Diagnosis is difficult due to overlapping symptoms with other conditions and a lack of universall
Externí odkaz:
https://doaj.org/article/08c99fd4ab8641dbb53712dc48e38f47
Autor:
Ronald J. Ellis, Ronald J. Bosch, Ann C. Collier, Marlene Smurzynski, Kevin Robertson, Hamza Coban, Kunling Wu, Supriya Krishnan
Publikováno v:
AIDS (London, England), vol 31, iss 11
Background Despite treatment with virologically suppressive antiretroviral therapy (ART), neurocognitive impairment may persist or develop de novo in aging HIV-infected individuals. We evaluated advancing age as a predictor of neurocognitive impairme
Autor:
A Team, Supriya Krishnan, Ann C. Collier, Constance A. Benson, Judith Feinberg, Ronald J. Bosch, Susan L. Koletar, Marlene Smurzynski, Allrt, Kunling Wu, M.K. Klebert
Publikováno v:
HIV Clinical Trials. 12:190-200
Examine incidence and factors associated with loss to follow-up (LTFU) in the AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) cohort.ALLRT is a prospective cohort of HIV-infected persons randomized to antiretroviral (A
Autor:
Ann C. Collier, David B. Clifford, Scott R. Evans, Ronald J. Bosch, Kevin Robertson, Kunling Wu, Michael Taylor, Marlene Smurzynski, Ronald J. Ellis, Scott Letendre
Publikováno v:
AIDS. 25:357-365
Objective: Differences in antiretroviral distribution into the central nervous system (CNS) may impact neurocognitive status. We assessed the relationship between estimates of antiretroviral therapy penetration into the CNS, using a published ranking
Autor:
Jennifer Uyanik, Joseph J. Eron, Kristine B. Patterson, Marlene Smurzynski, Susan E. Cohn, Michael Hughes
Publikováno v:
Clinical Infectious Diseases. 49:473-476
Menopause may affect antiretroviral treatment (ART) response. Immunologic and virologic responses to ART were compared in 220 premenopausal and 47 postmenopausal women enrolled in 2 studies involving ART-naive persons. Changes in CD4 counts or human
Publikováno v:
Antiviral Therapy. 14:853-858
Background We aimed to determine whether statin exposure in antiretroviral-treated individuals is associated with increases in hip circumference compared with HIV treatment without concomitant statin use. Methods This was a prospective multicentre co
Autor:
Kunling Wu, Susan L. Koletar, Constance A. Benson, Ann C. Collier, Marlene Smurzynski, Ronald J. Bosch, Barbara Bastow
Publikováno v:
HIV Clinical Trials. 9:269-282
ALLRT is a longitudinal cohort study of HIV-infected subjects prospectively randomized into selected clinical trials for antiretroviral (ARV) treatment-naïve and ARV treatment-experienced individuals conducted by the AIDS Clinical Trials Group (ACTG
Publikováno v:
AIDS Education and Prevention. 19:173-186
Although outreach frequently is used to provide community-based HIV prevention services to members of underserved populations, researchers may not be familiar with the specific components of and factors influencing outreach and how systematic communi
Autor:
Joseph J. Eron, Camlin Tierney, Lauren O'Keefe, Eric S. Daar, Marlene Smurzynski, Paul E. Sax, Katie R. Mollan, Thomas B. Campbell, Roy M. Gulick, Lumine Na, Kevin Robertson
Publikováno v:
Annals of internal medicine. 161(1)
The relationship between efavirenz use and suicidality is not well-defined.To compare time to suicidality with efavirenz-containing versus efavirenz-free antiretroviral regimens for initial treatment of HIV.Participant-level data were analyzed from 4
Autor:
Vinh Pham, Judith A. Aberg, Marlene Smurzynski, Minhee Kang, Susan L. Koletar, Kunling Wu, Kimberly Hollabaugh
OBJECTIVES To characterize HIV/hepatitis B virus (HBV) coinfection in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort and compare long-term HBV outcomes between regimens with 1 (MONO) or 2 (DUAL) anti-HBV agents. DESIGN A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05dd9ba7ab945bb34c53a8aec4774dc5
https://europepmc.org/articles/PMC4169110/
https://europepmc.org/articles/PMC4169110/